Akebia Therapeutics reported $52.5M in Operating Profit for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acadia Pharmaceuticals ACAD:US $ -33.65M 79.36M
Agios Pharmaceuticals AGIO:US $ -94.94M 3.5M
Akebia Therapeutics AKBA:US $ 52.5M 111M
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Amgen AMGN:US $ 2176M 324M
Ardelyx ARDX:US $ -26.22M 1.59M
Astellas Pharma 4503:JP Y 33147M 46832M
AstraZeneca AZN:LN 44.27B 22.58B
Avrobio Inc AVRO:US -27774000 1.64M
Bayer BAYN:GR 169M 4.04B
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
Exelixis EXEL:US $ 83.71M 0.46M
Fresenius Medical Care FME:GR € 341M 6.67M
GlaxoSmithKline GSK:LN 108.1B 121.2B
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
Ironwood Pharmaceuticals IRWD:US $ 55.66M 2.19M
Johnson & Johnson JNJ:US $ 5840M 22M
Karyopharm Therapeutics KPTI:US $ -42908000 8.32M
Lexicon Pharmaceuticals LXRX:US -24007000 627K
Moderna Inc MRNA:US 2.45B 1.78B
Nektar Therapeutics NKTR:US $ -152.84M 36.28M
Opko Health OPK:US $ -10.74M 61.68M
Prothena PRTA:US -43209000 5.26M
Ptc Therapeutics PTCT:US $ -92.36M 5.84M
Regeneron Pharmaceuticals REGN:US $ 1109.9M 148.6M
Sarepta Therapeutics SRPT:US $ -211.13M 124.25M
Seattle Genetics SGEN:US $ -133.11M 0.06M
Vanda Pharmaceuticals VNDA:US $ 3.46M 11.13M